According to a new report LAMEA Hybrid Imaging Market, published by KBV Research, the LAMEA Hybrid Imaging Market would witness market growth of 5.48% CAGR during the forecast period (2019-2025).
The Brazil market dominated the LAMEA Hospitals Market by Country in 2018, and would continue to be a dominant market till 2025. The Argentina market is estimated to witness a CAGR of 5.8% during (2019 - 2025). Additionally, The UAE market would witness a CAGR of 4.6% during (2019 - 2025).
The Oncology market dominated the Saudi Arabia Hybrid Imaging Market by Application in 2018, growing at a CAGR of 4.9 % during the forecast period. The Cardiology market is expected to witness a CAGR of 6.6% during (2019 - 2025). The Brain & Neurology market is experiencing a CAGR of 6.4% during (2019 - 2025).
The PET/CT systems market dominated the South Africa Hybrid Imaging Market by Type in 2018thereby, achieving a market value of $32.9 million by 2025. The SPET/CT systems market is exhibiting a CAGR of 5.4% during (2019 - 2025). The OCT/Fundus Imaging System market would prosper at a CAGR of 6.4% during (2019 - 2025).
Structural Insights: https://www.kbvresearch.com/lamea-hybrid-imaging-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Siemens AG (Siemens Healthineers), Canon, Inc. (Canon Medical Systems Corporation), General Electric (GE) Co. (GE Healthcare), Hitachi, Ltd. (Hitachi Healthcare), Koninklijke Philips N.V., PerkinElmer, Inc., Bruker Corporation, Atlantis Worldwide, LLC, Cubersa, Inc., Amber Diagnostics, Inc.
By Application
By Type
By End User
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
